Thirty out of the 41 analysts tracking the company have a 'buy' rating on the stock, seven suggest a 'hold' and four have a ...

Stay up-to-date with the Sun Pharma Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on ...

How will India’s leading drugmaker handle legal setbacks, volatile market trends, and competition in generics and specialty products?

Stay informed with the Sun Pharma Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of ...

After a US Court blocked the launch of Leqselvi, a drug used to treat severe alopecia areata, shares of Sun Pharma plunged ...

This decision delays Sun Pharma's planned US launch of the product, which could be deferred for several months if the company ...

Shares of several companies including M&M, Bharti Airtel, Nykaa, and Sun Pharma, among others, will be in the news today on ...

According to Citi, the delay in the launch of Sun Pharma's alopecia areata drug, Leqselvi, could impact its near-term ...

Sun Pharmaceuticals Ltd. announced on Saturday that the US District Court of New Jersey has granted a preliminary injunction ...

What is the Sun Pharmaceuticals Industries Ltd share price today? The Sun Pharmaceuticals Industries Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹1869.75 today. What is the Market Cap ...

In the corresponding quarter of the previous fiscal, Sun Pharma Advanced Research Company posted a net loss of ₹86.4 crore, ...